Cell and Gene Therapy 19/11/2019 Reducing complexity in clinical translation and scale-up of... An interview with Dr Jon Rowley, Founder and Chief Product Officer, RoosterBio, Inc
Cell and Gene Therapy 08/11/2019 The A-Z of Advanced Therapies Phacilitate's picks of the A to Z of advanced therapies
Cell and Gene Therapy 07/11/2019 Phacilitate Working Group Report: Standardising Tubing Connectivity A summary report of the working group for sterile tubing connectivity meeting to discuss guidance documentation
Cell and Gene Therapy 07/11/2019 Accelerating Advanced Therapy Treatments with the FDA’s RMAT... An introduction to the FDA’s RMAT designation with Dr Julie Allickson, Director, Regenerative Medicine Clinical Center at Wake Forest Institute for...
Cell and Gene Therapy 29/10/2019 Innovations for Scalable Manufacturing of Allogeneic Cell Therapy... Allogeneic cell therapies are poised to become a new frontier for therapeutic medicines. However, reliable and scalable manufacturing technology is...
Cell and Gene Therapy 21/10/2019 [WEBINAR] Is a non-viral gene editing approach the answer to... Exploring the next generation of non-viral gene-editing technologies, in partnership with Avectas
Cell and Gene Therapy 09/10/2019 Automation Special Interest Group: Report 2019 The 2019 Automation SIG identified some of the biggest opportunities to improve manufacturing efficiency and accuracy. This report comprises 14...
Cell and Gene Therapy 08/10/2019 [WEBINAR] Overcoming the shortages in cell and gene therapy... A panel of advanced therapy manufacturing experts explore strategies to overcome the global manufacturing shortage
Cell and Gene Therapy 07/10/2019 [Blog] Measuring success from conferences is getting harder, here&... A case study from the Business of Regenerative Medicine 2019
Cell and Gene Therapy 07/10/2019 60 seconds with... Dr Angela Colbert, Knight Vice President Education at the Frost Science Museum, Miami
Cell and Gene Therapy 25/09/2019 Functionality of non-virally transfected T cells A summary of Dr Shirley O'Dea's presentation and data from Phacilitate Leaders Europe
Cell and Gene Therapy 12/09/2019 60 Seconds with...Frances Pang, Orchard Therapeutics Frances Pang, VP Global Market Access at Orchard Therapeutics on evolving access and reimbursement structures, HTA engagement and commercial success
Cell and Gene Therapy 03/09/2019 60 Seconds with...Pilar Pinilla-Dominguez, NICE Pilar Pinilla-Dominguez, Senior Scientific Adviser at NICE on reimbursement models for advanced therapies
Cell and Gene Therapy 30/08/2019 Space is the Next Frontier for Global Pharma Episode six with Jana Stoudemire, Chief Commercialisation Officer, Space Tango
Cell and Gene Therapy 30/08/2019 The Next Generation of Gene Therapy: A Panoramic View of the New... Episode five with Jessica Carmen, Consultant, Pullan Consulting
